analysis – Our Curious Amalgam

Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

#172 Biologically Similar but Competitively Not So? Economic Considerations of IP Litigation Settlements Involving Biosimilars

Posted 12 months ago Tagged analysis antitrust biologics biosimilars competition economics generics intellectual property law litigation market payment pharmaceutical settlement

Under the U.S. Supreme Court case FTC v. Actavis (2013), antitrust analysis of “reverse settlements” […]

David Neill, Of Counsel, Wachtell, Lipton, Rosen & Katz

#143 Does U.S. Bank Merger Enforcement Need To Be Revitalized? A Conversation With David Neill

Posted 2 years ago Tagged acquisitions agency analysis antitrust bank financial FinTech merger online banking Reform regulation

U.S. bank mergers are on the rise and so are claims that agencies “rubber stamp” […]

Dr. Rosa Abrantes-Metz, the Brattle Group

#88 What’s in a Screen? Using Data as Evidence of Collusion and Manipulation (or lack thereof)

Posted 3 years ago Tagged analysis antitrust cartel collusion compliance data economic manipulation screening

Screening out potential collusion and manipulation is the key to corporations’ antitrust compliance by flagging […]